These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27585216)

  • 1. Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation.
    Chun BY; Rizzo JF
    Curr Opin Ophthalmol; 2016 Nov; 27(6):475-480. PubMed ID: 27585216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
    Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
    Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations.
    Yu-Wai-Man P; Bailie M; Atawan A; Chinnery PF; Griffiths PG
    Eye (Lond); 2011 May; 25(5):596-602. PubMed ID: 21378995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
    Chun BY; Rizzo JF
    Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
    Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
    Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of dominant optic atrophy: what do they tell us about the pathophysiology of visual loss?
    Williams PA; Morgan JE; Votruba M
    Vision Res; 2011 Jan; 51(2):229-34. PubMed ID: 20801145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.
    Zanna C; Ghelli A; Porcelli AM; Karbowski M; Youle RJ; Schimpf S; Wissinger B; Pinti M; Cossarizza A; Vidoni S; Valentino ML; Rugolo M; Carelli V
    Brain; 2008 Feb; 131(Pt 2):352-67. PubMed ID: 18222991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal dysfunction characterizes subtypes of dominant optic atrophy.
    Cascavilla ML; Parisi V; Triolo G; Ziccardi L; Borrelli E; Di Renzo A; Balducci N; Lamperti C; Bianchi Marzoli S; Darvizeh F; Sadun AA; Carelli V; Bandello F; Barboni P
    Acta Ophthalmol; 2018 Mar; 96(2):e156-e163. PubMed ID: 28926202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy.
    Alavi MV; Bette S; Schimpf S; Schuettauf F; Schraermeyer U; Wehrl HF; Ruttiger L; Beck SC; Tonagel F; Pichler BJ; Knipper M; Peters T; Laufs J; Wissinger B
    Brain; 2007 Apr; 130(Pt 4):1029-42. PubMed ID: 17314202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early macular retinal ganglion cell loss in dominant optic atrophy: genotype-phenotype correlation.
    Barboni P; Savini G; Cascavilla ML; Caporali L; Milesi J; Borrelli E; La Morgia C; Valentino ML; Triolo G; Lembo A; Carta A; De Negri A; Sadun F; Rizzo G; Parisi V; Pierro L; Bianchi Marzoli S; Zeviani M; Sadun AA; Bandello F; Carelli V
    Am J Ophthalmol; 2014 Sep; 158(3):628-36.e3. PubMed ID: 24907432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells.
    Sladen PE; Jovanovic K; Guarascio R; Ottaviani D; Salsbury G; Novoselova T; Chapple JP; Yu-Wai-Man P; Cheetham ME
    Hum Mol Genet; 2022 Oct; 31(20):3478-3493. PubMed ID: 35652445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant optic atrophy.
    Lenaers G; Hamel C; Delettre C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P; Milea D
    Orphanet J Rare Dis; 2012 Jul; 7():46. PubMed ID: 22776096
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Nitta Y; Osaka J; Maki R; Hakeda-Suzuki S; Suzuki E; Ueki S; Suzuki T; Sugie A
    Elife; 2024 Aug; 12():. PubMed ID: 39177028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
    Delettre C; Lenaers G; Pelloquin L; Belenguer P; Hamel CP
    Mol Genet Metab; 2002 Feb; 75(2):97-107. PubMed ID: 11855928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment.
    Yarosh W; Monserrate J; Tong JJ; Tse S; Le PK; Nguyen K; Brachmann CB; Wallace DC; Huang T
    PLoS Genet; 2008 Jan; 4(1):e6. PubMed ID: 18193945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.
    Sarzi E; Seveno M; Angebault C; Milea D; Rönnbäck C; Quilès M; Adrian M; Grenier J; Caignard A; Lacroux A; Lavergne C; Reynier P; Larsen M; Hamel CP; Delettre C; Lenaers G; Müller A
    Hum Mol Genet; 2016 Jun; 25(12):2539-2551. PubMed ID: 27260406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPA1: How much do we know to approach therapy?
    Del Dotto V; Fogazza M; Lenaers G; Rugolo M; Carelli V; Zanna C
    Pharmacol Res; 2018 May; 131():199-210. PubMed ID: 29454676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creation of an Isogenic Human iPSC-Based RGC Model of Dominant Optic Atrophy Harboring the Pathogenic Variant c.1861C>T (p.Gln621Ter) in the
    García-López M; Jiménez-Vicente L; González-Jabardo R; Dorado H; Gómez-Manjón I; Martín MÁ; Ayuso C; Arenas J; Gallardo ME
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations.
    Rocca MA; Bianchi-Marzoli S; Messina R; Cascavilla ML; Zeviani M; Lamperti C; Milesi J; Carta A; Cammarata G; Leocani L; Lamantea E; Bandello F; Comi G; Falini A; Filippi M
    J Neurol; 2015 May; 262(5):1216-27. PubMed ID: 25794858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
    Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
    J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.